Table 3.
Index | SL (SV1 + RV5)
|
Cornell (SV3 + RaVL)
|
CP (SV3 + RaVL) × QRS duration
|
||||
---|---|---|---|---|---|---|---|
R | P-value | R | P-value | R | P-value | ||
| |||||||
LVM/BSA | |||||||
| |||||||
Total | 0.15 | <0.001 | 0.16 | <0.001 | 0.18 | <0.001 | |
Male | 0.23 | <0.001 | 0.17 | <0.001 | 0.21 | <0.001 | |
Female | 0.09 | <0.01 | 0.15 | <0.001 | 0.16 | <0.001 | |
| |||||||
LVM/height2.7 | |||||||
| |||||||
Total | 0.09 | <0.001 | 0.15 | <0.001 | 0.21 | <0.001 | |
Male | 0.20 | <0.001 | 0.17 | <0.001 | 0.21 | <0.001 | |
Female | 0.05 | 0.091 | 0.17 | <0.001 | 0.17 | <0.001 |
Note: Pearson’s correlation analysis was applied between the electrocardiographic and echocardiographic parameters for the detection of LVH in total participants, in both males and females.
Abbreviations: BSA, body surface area; CP, Cornell Product; LVM, left ventricular mass; RaVL, R wave of lead aVL; RV5, R wave of lead V5; SL, Sokolow-Lyon; SV1, S wave of the leads V1; SV3, S wave of the leads V3.